Literature DB >> 23453971

Crystal structure and mechanism of activation of TANK-binding kinase 1.

Amede Larabi1, Juliette M Devos, Sze-Ling Ng, Max H Nanao, Adam Round, Tom Maniatis, Daniel Panne.   

Abstract

Tank-binding kinase I (TBK1) plays a key role in the innate immune system by integrating signals from pattern-recognition receptors. Here, we report the X-ray crystal structures of inhibitor-bound inactive and active TBK1 determined to 2.6 Å and 4.0 Å resolution, respectively. The structures reveal a compact dimer made up of trimodular subunits containing an N-terminal kinase domain (KD), a ubiquitin-like domain (ULD), and an α-helical scaffold dimerization domain (SDD). Activation rearranges the KD into an active conformation while maintaining the overall dimer conformation. Low-resolution SAXS studies reveal that the missing C-terminal domain (CTD) extends away from the main body of the kinase dimer. Mutants that interfere with TBK1 dimerization show significantly reduced trans-autophosphorylation but retain the ability to bind adaptor proteins through the CTD. Our results provide detailed insights into the architecture of TBK1 and the molecular mechanism of activation.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23453971     DOI: 10.1016/j.celrep.2013.01.034

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  72 in total

1.  Glycolipid iGb3 feedback amplifies innate immune responses via CD1d reverse signaling.

Authors:  Xingguang Liu; Peng Zhang; Yunkai Zhang; Zheng Wang; Sheng Xu; Yingke Li; Wanwan Huai; Qingqing Zhou; Xiang Chen; Xi Chen; Nan Li; Peng Wang; Yunsen Li; Xuetao Cao
Journal:  Cell Res       Date:  2018-12-04       Impact factor: 25.617

2.  Zika virus NS5 protein antagonizes type I interferon production via blocking TBK1 activation.

Authors:  Shaoli Lin; Shixing Yang; Jia He; Johnathan D Guest; Zexu Ma; Liping Yang; Brian G Pierce; Qiyi Tang; Yan-Jin Zhang
Journal:  Virology       Date:  2018-12-06       Impact factor: 3.616

3.  Evasion of antiviral immunity through sequestering of TBK1/IKKε/IRF3 into viral inclusion bodies.

Authors:  Xiaodong Wu; Xian Qi; Bingqian Qu; Zerui Zhang; Mifang Liang; Chuan Li; Carol J Cardona; Dexin Li; Zheng Xing
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

4.  TRIM14 Is a Key Regulator of the Type I IFN Response during Mycobacterium tuberculosis Infection.

Authors:  Caitlyn T Hoffpauir; Samantha L Bell; Kelsi O West; Tao Jing; Allison R Wagner; Sylvia Torres-Odio; Jeffery S Cox; A Phillip West; Pingwei Li; Kristin L Patrick; Robert O Watson
Journal:  J Immunol       Date:  2020-05-13       Impact factor: 5.422

5.  HSV-1 ICP27 targets the TBK1-activated STING signalsome to inhibit virus-induced type I IFN expression.

Authors:  Maria H Christensen; Søren B Jensen; Juho J Miettinen; Stefanie Luecke; Thaneas Prabakaran; Line S Reinert; Thomas Mettenleiter; Zhijian J Chen; David M Knipe; Rozanne M Sandri-Goldin; Lynn W Enquist; Rune Hartmann; Trine H Mogensen; Stephen A Rice; Tuula A Nyman; Sampsa Matikainen; Søren R Paludan
Journal:  EMBO J       Date:  2016-05-27       Impact factor: 11.598

6.  Two Conserved Amino Acids within the NSs of Severe Fever with Thrombocytopenia Syndrome Phlebovirus Are Essential for Anti-interferon Activity.

Authors:  Miyu Moriyama; Manabu Igarashi; Takumi Koshiba; Takashi Irie; Ayato Takada; Takeshi Ichinohe
Journal:  J Virol       Date:  2018-09-12       Impact factor: 5.103

7.  E3 ubiquitin ligase RNF128 promotes innate antiviral immunity through K63-linked ubiquitination of TBK1.

Authors:  Guanhua Song; Bingyu Liu; Zhihui Li; Haifeng Wu; Peng Wang; Kai Zhao; Guosheng Jiang; Lei Zhang; Chengjiang Gao
Journal:  Nat Immunol       Date:  2016-10-24       Impact factor: 25.606

8.  Crystal structure of a human IκB kinase β asymmetric dimer.

Authors:  Shenping Liu; Yohann R Misquitta; Andrea Olland; Mark A Johnson; Kerry S Kelleher; Ron Kriz; Laura L Lin; Mark Stahl; Lidia Mosyak
Journal:  J Biol Chem       Date:  2013-06-21       Impact factor: 5.157

9.  Design, synthesis, and biological activity of substituted 2-amino-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylic acid derivatives as inhibitors of the inflammatory kinases TBK1 and IKKε for the treatment of obesity.

Authors:  Tyler S Beyett; Xinmin Gan; Shannon M Reilly; Andrew V Gomez; Louise Chang; John J G Tesmer; Alan R Saltiel; Hollis D Showalter
Journal:  Bioorg Med Chem       Date:  2018-09-20       Impact factor: 3.641

10.  Effects of ALS-associated TANK binding kinase 1 mutations on protein-protein interactions and kinase activity.

Authors:  Junqiang Ye; Jonah Cheung; Valeria Gerbino; Göran Ahlsén; Christina Zimanyi; David Hirsh; Tom Maniatis
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.